Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript

Novavax, Inc. (NASDAQ:NVAX) JPMorgan 42nd Annual Healthcare Conference January 8, 2024 8:15 PM ET Company Participants John Jacobs - President and CEO John Trizzino - Chief Commercial Officer & Chief Business Officer James Kelly - CFO Filip Dubovsky - President of Research & Development Conference Call Participants Eric Joseph - JPMorgan Eric Joseph All right, okay. We'll get started here. I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. And our next presenting company is Novavax. Presenting on behalf ...